Please Wait.....
Report
AI in Remote Patient Monitoring (RPM) - Company Evaluation Report, 2024
Market Report I 2025-08-01 I 156 Pages I MarketsandMarkets
The AI in Remote Patient Monitoring Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for AI in Remote Patient Monitoring. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 100 companies, of which the Top 19 AI in Remote Patient Monitoring Companies were categorized and recognized as the quadrant leaders.
Over the years, the AI in Remote Patient Monitoring (RPM) market has experienced substantial progress, driven by healthcare reforms implemented across both developed and developing countries. AI-powered RPM solutions have proven to be effective in improving patient outcomes while significantly reducing healthcare costs. The primary drivers of this market include the increasing elderly population requiring continuous monitoring for chronic illnesses and the ongoing transition to value-based care frameworks. Moreover, advances in artificial intelligence and machine learning, coupled with enhanced internet accessibility, have facilitated real-time data sharing. The growing emphasis on personalized medical care, along with regulatory encouragement for telehealth and remote services, continues to accelerate market expansion.
AI in RPM involves the incorporation of artificial intelligence into remote healthcare systems designed to monitor and manage patient health outside traditional clinical environments. These systems rely on wearable devices and at-home medical monitors that collect continuous health data, while AI algorithms analyze this data to detect anomalies, assess risks, and notify medical professionals when intervention is necessary. By processing information in real time, AI identifies patterns, anticipates health complications, and ensures that timely, personalized care is delivered. This not only enables early diagnosis and treatment but also reduces unnecessary hospital admissions, ultimately enhancing the overall quality of patient care.
The 360 Quadrant maps the AI in Remote Patient Monitoring companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the AI in Remote Patient Monitoring quadrant. The top criteria for product footprint evaluation included By COMPONENT (Devices, Software, Services), By INDICATION (Oncology, Cardiology, Neurology, Diabetes, Sleep Disorders, Respiratory Diseases, Wellness Improvement, Mental Health Disorders, Other Indications), and By END USER (Healthcare Providers, Healthcare Payers, Patients, Pharmaceutical & Biotechnology Companies, Medtech Companies, Other End Users).
Key Players
Key players in the Ai in Remote Patient Monitoring market include major global corporations and specialized innovators such as Medtronic, Koninklijke Philips N.V., Ge Healthcare, Boston Scientific Corporation, Omron Healthcare, Inc., Resmed, Inc., Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd. (Roche, Diagnostics), Irhythm Inc., Beijing Choice Electronic Tech Co., Ltd., Biotronik, Alivecor, Inc., Masimo, Dexcom, Inc., Biobeat, Tytocare Ltd., Zeto Inc., Glooko, Inc., Welldoc, Inc., and Turtle Shell Technologies Pvt. Ltd. (Dozee). These companies are actively investing in research and development, forming strategic partnerships, and engaging in collaborative initiatives to drive innovation, expand their global footprint, and maintain a competitive edge in this rapidly evolving market.
Top Three Companies Analysis
Medtronic
Medtronic is recognized for its pioneering work in diabetes management and cardiac rhythm disease management solutions. The company's strong Company Product Portfolio includes advanced remote patient monitoring systems that demonstrate robust Company Market Share. Recent collaborations with Cardiac Design Labs and Abbott enhance Medtronic's offerings, aiming to improve patient outcomes through integrated AI solutions. The consistent revenue growth from 2019 to 2023 underscores Medtronic's stable presence and leadership in the industry.
Koninklijke Philips N.V.
Koninklijke Philips N.V. stands out for its innovative AI solutions in remote monitoring, having shown significant revenue growth trends. Philips' extensive Company Profiles highlight achievements in product launches and strategic acquisitions that bolster its market position. The company actively expands into emerging markets, leveraging its advanced healthcare technologies to capture further Company Market Share. Philips' dedication to evolving healthcare needs solidifies its ranking among top industry leaders.
GE Healthcare
GE Healthcare focuses on expanding its Connected Care segment with durable strategic initiatives. Its strong Company Product Portfolio in patient monitoring and AI integration drives significant Company Market Share. Recognized for successful partnerships and technological innovations, GE Healthcare continues to enhance its market footprint across diverse regions. The company's strategic focus on enhancing RPM solutions through AI underlines its commitment to providing cutting-edge healthcare technologies.
1 INTRODUCTION 16
1.1 MARKET DEFINITION 16
1.2 INCLUSIONS & EXCLUSIONS 16
1.3 STAKEHOLDERS 17
2 EXECUTIVE SUMMARY 18
3 MARKET OVERVIEW 22
3.1 INTRODUCTION 22
3.2 MARKET DYNAMICS 22
3.2.1 DRIVERS 24
3.2.1.1 Expanding telehealth and remote patient monitoring markets 24
3.2.1.2 Increasing prevalence of chronic diseases 25
3.2.1.3 Focus on development and adoption of mHealth applications 25
3.2.1.4 Increased government support and favorable reimbursement policies 26
3.2.1.5 Growing awareness about lifestyle management and
home healthcare 26
3.2.2 RESTRAINTS 27
3.2.2.1 Regulatory variations across regions 27
3.2.2.2 Shortage of skilled professionals to operate
AI-based remote patient monitoring tools 27
3.2.2.3 Data security concerns 28
3.2.3 OPPORTUNITIES 28
3.2.3.1 Growing demand for personalized medicines and care plans 28
3.2.3.2 Increase in partnerships and collaborations among healthcare providers and AI-based companies 29
3.2.3.3 Growth opportunities in emerging economies 30
3.2.3.4 Rising investment in AI-based remote patient monitoring solutions 30
3.2.4 CHALLENGES 31
3.2.4.1 Scarcity of high-quality healthcare data and privacy concerns 31
3.2.4.2 Reluctance among healthcare professionals to adopt AI in remote patient monitoring devices 31
3.2.4.3 Lack of interoperability 32
3.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS 32
3.4 INDUSTRY TRENDS 33
3.4.1 SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE 33
3.4.2 INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGIES 33
3.5 ECOSYSTEM ANALYSIS 33
3.5.1 ROLE IN ECOSYSTEM 35
3.6 VALUE CHAIN ANALYSIS 36
3.7 TECHNOLOGY ANALYSIS 37
3.7.1 KEY TECHNOLOGIES 37
3.7.1.1 Wearable devices and sensors 37
3.7.1.2 AI and ML 37
3.7.1.3 Predictive analytics 38
3.7.2 COMPLEMENTARY TECHNOLOGIES 38
3.7.2.1 mHealth applications 38
3.7.2.2 Cloud computing 38
3.7.2.3 Digital health platforms 39
3.7.3 ADJACENT TECHNOLOGIES 39
3.7.3.1 Point-of-care diagnostics 39
3.7.3.2 Smart home health devices 39
3.8 PORTER'S FIVE FORCES ANALYSIS 40
3.8.1 INTENSITY OF COMPETITIVE RIVALRY 40
3.8.2 BARGAINING POWER OF BUYERS 41
3.8.3 THREAT OF SUBSTITUTES 41
3.8.4 THREAT OF NEW ENTRANTS 41
3.8.5 BARGAINING POWER OF SUPPLIERS 41
3.9 PATENT ANALYSIS 41
3.9.1 PATENT PUBLICATION TRENDS 41
3.9.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR
AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS 42
3.9.3 TOP PATENT OWNERS/APPLICANTS IN AI IN REMOTE
PATIENT MONITORING MARKET 43
3.9.4 LIST OF KEY PATENTS/PATENT APPLICATIONS 44
3.10 KEY CONFERENCES & EVENTS, 2025-2026 46
4 COMPETITIVE LANDSCAPE 47
4.1 INTRODUCTION 47
4.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 47
4.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS FOR AI IN
REMOTE PATIENT MONITORING MARKET 48
4.3 REVENUE ANALYSIS, 2019-2023 50
4.4 MARKET SHARE ANALYSIS, 2023 51
4.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 54
4.5.1 STARS 54
4.5.2 EMERGING LEADERS 54
4.5.3 PERVASIVE PLAYERS 54
4.5.4 PARTICIPANTS 54
4.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 56
4.5.5.1 Company footprint 56
4.5.5.2 Region footprint 57
4.5.5.3 Component footprint 58
4.5.5.4 Indication footprint 59
4.5.5.5 End-user footprint 60
4.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 61
4.6.1 PROGRESSIVE COMPANIES 61
4.6.2 RESPONSIVE COMPANIES 61
4.6.3 DYNAMIC COMPANIES 61
4.6.4 STARTING BLOCKS 61
4.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 63
4.6.5.1 Detailed list of key startups/SMEs 63
4.6.5.2 Competitive benchmarking of key emerging players/startups 63
4.7 COMPANY VALUATION & FINANCIAL METRICS 64
4.7.1 FINANCIAL METRICS 64
4.7.2 COMPANY VALUATION 64
4.8 BRAND/SOFTWARE COMPARISON 65
4.9 COMPETITIVE SCENARIO 66
4.9.1 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS 66
4.9.2 DEALS 67
4.9.3 EXPANSIONS 68
4.9.4 OTHER DEVELOPMENTS 68
5 COMPANY PROFILES 69
5.1 KEY PLAYERS 69
5.1.1 MEDTRONIC 69
5.1.1.1 Business overview 69
5.1.1.2 Products/Services/Solutions offered 70
5.1.1.3 Recent developments 72
5.1.1.3.1 Product approvals 72
5.1.1.3.2 Deals 72
5.1.1.4 MnM view 73
5.1.1.4.1 Right to win 73
5.1.1.4.2 Strategic choices 73
5.1.1.4.3 Weaknesses & competitive threats 73
5.1.2 KONINKLIJKE PHILIPS N.V. 74
5.1.2.1 Business overview 74
5.1.2.2 Products/Services/Solutions offered 75
5.1.2.3 Recent developments 77
5.1.2.3.1 Product launches & approvals 77
5.1.2.3.2 Deals 78
5.1.2.4 MnM view 80
5.1.2.4.1 Right to win 80
5.1.2.4.2 Strategic choices 80
5.1.2.4.3 Weaknesses & competitive threats 80
5.1.3 GE HEALTHCARE 81
5.1.3.1 Business overview 81
5.1.3.2 Products/Services/Solutions offered 82
5.1.3.3 Recent developments 83
5.1.3.3.1 Deals 83
5.1.3.4 MnM view 84
5.1.3.4.1 Right to win 84
5.1.3.4.2 Strategic choices 84
5.1.3.4.3 Weaknesses & competitive threats 84
5.1.4 BOSTON SCIENTIFIC CORPORATION 85
5.1.4.1 Business overview 85
5.1.4.2 Products/Services/Solutions offered 86
5.1.4.3 Recent developments 87
5.1.4.3.1 Product launches 87
5.1.4.3.2 Deals 88
5.1.4.3.3 Expansions 88
5.1.4.3.4 Other developments 89
5.1.4.4 MnM view 89
5.1.4.4.1 Right to win 89
5.1.4.4.2 Strategic choices 89
5.1.4.4.3 Weaknesses & competitive threats 89
5.1.5 OMRON HEALTHCARE, INC. 90
5.1.5.1 Business overview 90
5.1.5.2 Products/Services/Solutions offered 91
5.1.5.3 Recent developments 93
5.1.5.3.1 Product approvals & enhancements 93
5.1.5.3.2 Deals 93
5.1.5.4 MnM view 94
5.1.5.4.1 Right to win 94
5.1.5.4.2 Strategic choices 94
5.1.5.4.3 Weaknesses & competitive threats 94
5.1.6 RESMED, INC. 95
5.1.6.1 Business overview 95
5.1.6.2 Products/Services/Solutions offered 96
5.1.6.3 Recent developments 98
5.1.6.3.1 Product launches & enhancements 98
5.1.6.3.2 Deals 99
5.1.6.3.3 Expansions 99
5.1.6.3.4 Other developments 100
5.1.7 NIHON KOHDEN CORPORATION 101
5.1.7.1 Business overview 101
5.1.7.2 Products/Services/Solutions offered 102
5.1.7.3 Recent developments 105
5.1.7.3.1 Product launches & approvals 105
5.1.7.3.2 Deals 106
5.1.7.3.3 Other developments 106
5.1.8 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS) 107
5.1.8.1 Business overview 107
5.1.8.2 Products/Services/Solutions offered 108
5.1.8.3 Recent developments 109
5.1.8.3.1 Product launches & approvals 109
5.1.8.3.2 Deals 110
5.1.9 IRHYTHM INC. 111
5.1.9.1 Business overview 111
5.1.9.2 Products/Services/Solutions offered 112
5.1.9.3 Recent developments 113
5.1.9.3.1 Product launches & approvals 113
5.1.9.3.2 Deals 114
5.1.10 BEIJING CHOICE ELECTRONIC TECH CO., LTD. 115
5.1.10.1 Business overview 115
5.1.10.2 Products/Services/Solutions offered 115
5.1.11 BIOTRONIK 117
5.1.11.1 Business overview 117
5.1.11.2 Products/Services/Solutions offered 117
5.1.11.3 Recent developments 118
5.1.11.3.1 Product launches & approvals 118
5.1.11.3.2 Deals 118
5.1.12 ALIVECOR, INC. 119
5.1.12.1 Business overview 119
5.1.12.2 Products/Services/Solutions offered 119
5.1.12.3 Recent developments 120
5.1.12.3.1 Product launches & approvals 120
5.1.12.3.2 Deals 121
5.1.12.3.3 Other developments 122
5.1.13 MASIMO 123
5.1.13.1 Business overview 123
5.1.13.2 Products/Services/Solutions offered 124
5.1.13.3 Recent developments 125
5.1.13.3.1 Product approvals & enhancements 125
5.1.13.4 Recent developments 126
5.1.13.4.1 Deals 126
5.1.14 DEXCOM, INC. 127
5.1.14.1 Business overview 127
5.1.14.2 Products/Services/Solutions offered 128
5.1.14.3 Recent developments 129
5.1.14.3.1 Product launches & approvals 129
5.1.14.3.2 Deals 130
5.1.15 BIOBEAT 131
5.1.15.1 Business overview 131
5.1.15.2 Products/Services/Solutions offered 131
5.1.15.3 Recent developments 132
5.1.15.3.1 Product launches & approvals 132
5.1.15.3.2 Deals 133
5.1.16 TYTOCARE LTD. 135
5.1.16.1 Business overview 135
5.1.16.2 Products/Services/Solutions offered 135
5.1.16.3 Recent developments 136
5.1.16.3.1 Product enhancements 136
5.1.16.3.2 Deals 136
5.1.16.3.3 Other developments 136
5.1.17 ZETO INC. 137
5.1.17.1 Business overview 137
5.1.17.2 Products/Services/Solutions offered 137
5.1.18 GLOOKO, INC. 138
5.1.18.1 Business overview 138
5.1.18.2 Products/Services/Solutions offered 138
5.1.18.3 Recent developments 139
5.1.18.3.1 Product launches & enhancements 139
5.1.18.3.2 Deals 139
5.1.18.3.3 Other developments 140
5.1.19 WELLDOC, INC. 141
5.1.19.1 Business overview 141
5.1.19.2 Products/Services/Solutions offered 141
5.1.19.3 Recent developments 142
5.1.19.3.1 Product approvals & enhancements 142
5.1.19.3.2 Deals 142
5.1.20 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE) 144
5.1.20.1 Business overview 144
5.1.20.2 Products/Services/Solutions offered 144
5.1.20.3 Recent developments 145
5.1.20.3.1 Product approvals 145
5.1.20.3.2 Other developments 145
5.2 OTHER PLAYERS 146
5.2.1 BIOINTELLISENSE, INC. 146
5.2.2 BLUE SPARK TECHNOLOGIES, INC. 147
5.2.3 ACCURKARDIA, INC. 148
5.2.4 AION BIOSYSTEMS, INC. 148
5.2.5 BROOK INC. 149
6 APPENDIX 150
6.1 RESEARCH METHODOLOGY 150
6.1.1 RESEARCH DATA 150
6.1.1.1 Secondary data 151
6.1.1.2 Primary data 152
6.1.2 RISK ANALYSIS 152
6.1.3 RESEARCH LIMITATIONS 153
6.2 COMPANY EVALUATION MATRIX: METHODOLOGY 153
6.3 AUTHOR DETAILS 156
TABLE 1 AI IN REMOTE PATIENT MONITORING MARKET: INCLUSIONS & EXCLUSIONS 16
TABLE 2 AI IN REMOTE PATIENT MONITORING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 23
TABLE 3 RECENT DEVELOPMENTS IN AI-BASED SOLUTIONS FOR REMOTE PATIENT MONITORING, JANUARY 2022-DECEMBER 2024 24
TABLE 4 AI IN REMOTE PATIENT MONITORING MARKET: ROLE IN ECOSYSTEM 35
TABLE 5 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR
AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS 42
TABLE 6 AI IN REMOTE PATIENT MONITORING MARKET:
LIST OF PATENTS/PATENT APPLICATIONS 44
TABLE 7 AI IN REMOTE PATIENT MONITORING MARKET:
LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026 46
TABLE 8 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2021-JANUARY 2025 48
TABLE 9 AI IN REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION 52
TABLE 10 AI IN REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT 57
TABLE 11 AI IN REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT 58
TABLE 12 AI IN REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT 59
TABLE 13 AI IN REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT 60
TABLE 14 AI IN REMOTE PATIENT MONITORING MARKET:
DETAILED LIST OF KEY STARTUPS/SME PLAYERS 63
TABLE 15 AI IN REMOTE PATIENT MONITORING MARKET:
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 63
TABLE 16 AI IN REMOTE PATIENT MONITORING MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2021-JANUARY 2025 66
TABLE 17 AI IN REMOTE PATIENT MONITORING MARKET:
DEALS, JANUARY 2021-JANUARY 2025 67
TABLE 18 AI IN REMOTE PATIENT MONITORING MARKET:
EXPANSIONS, JANUARY 2021-JANUARY 2025 68
TABLE 19 AI IN REMOTE PATIENT MONITORING MARKET:
OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 68
TABLE 20 MEDTRONIC: COMPANY OVERVIEW 69
TABLE 21 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 70
TABLE 22 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025 72
TABLE 23 MEDTRONIC: DEALS, JANUARY 2021-JANUARY 2025 72
TABLE 24 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 74
TABLE 25 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 75
TABLE 26 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021-JANUARY 2025 77
TABLE 27 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021-JANUARY 2025 78
TABLE 28 GE HEALTHCARE: COMPANY OVERVIEW 81
TABLE 29 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 82
TABLE 30 GE HEALTHCARE: DEALS, JANUARY 2021-JANUARY 2025 83
TABLE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 85
TABLE 32 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 86
TABLE 33 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES,
JANUARY 2021-JANUARY 2025 87
TABLE 34 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021-JANUARY 2025 88
TABLE 35 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2021-JANUARY 2025 88
TABLE 36 BOSTON SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2021-JANUARY 2025 89
TABLE 37 OMRON HEALTHCARE, INC.: COMPANY OVERVIEW 90
TABLE 38 OMRON HEALTHCARE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 91
TABLE 39 OMRON HEALTHCARE, INC.: PRODUCT APPROVALS & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 93
TABLE 40 OMRON HEALTHCARE, INC.: DEALS, JANUARY 2021-JANUARY 2025 93
TABLE 41 RESMED, INC.: COMPANY OVERVIEW 95
TABLE 42 RESMED, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 96
TABLE 43 RESMED, INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 98
TABLE 44 RESMED, INC.: DEALS, JANUARY 2021-JANUARY 2025 99
TABLE 45 RESMED, INC.: EXPANSIONS, JANUARY 2021-JANUARY 2025 99
TABLE 46 RESMED, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 100
TABLE 47 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 101
TABLE 48 NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 102
TABLE 49 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021-JANUARY 2025 105
TABLE 50 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021-JANUARY 2025 106
TABLE 51 NIHON KOHDEN CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2021-JANUARY 2025 106
TABLE 52 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): COMPANY OVERVIEW 107
TABLE 53 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): PRODUCTS/SERVICES/SOLUTIONS OFFERED 108
TABLE 54 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS):
PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025 109
TABLE 55 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS):
DEALS, JANUARY 2021-JANUARY 2025 110
TABLE 56 IRHYTHM INC.: COMPANY OVERVIEW 111
TABLE 57 IRHYTHM INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 112
TABLE 58 IRHYTHM INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021-JANUARY 2025 113
TABLE 59 IRHYTHM INC.: DEALS, JANUARY 2021-JANUARY 2025 114
TABLE 60 BEIJING CHOICE ELECTRONIC TECH CO., LTD.: COMPANY OVERVIEW 115
TABLE 61 BEIJING CHOICE ELECTRONIC TECH CO., LTD.:
PRODUCTS/SERVICES/SOLUTIONS OFFERED 115
TABLE 62 BIOTRONIK: COMPANY OVERVIEW 117
TABLE 63 BIOTRONIK: PRODUCTS/SERVICES/SOLUTIONS OFFERED 117
TABLE 64 BIOTRONIK: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025 118
TABLE 65 BIOTRONIK: DEALS, JANUARY 2021-JANUARY 2025 118
TABLE 66 ALIVECOR, INC.: COMPANY OVERVIEW 119
TABLE 67 ALIVECOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 119
TABLE 68 ALIVECOR, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021-JANUARY 2025 120
TABLE 69 ALIVECOR, INC.: DEALS, JANUARY 2021-JANUARY 2025 121
TABLE 70 ALIVECOR, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 122
TABLE 71 MASIMO: COMPANY OVERVIEW 123
TABLE 72 MASIMO: PRODUCTS/SERVICES/SOLUTIONS OFFERED 124
TABLE 73 MASIMO: PRODUCT APPROVALS & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 125
TABLE 74 MASIMO: DEALS, JANUARY 2021-JANUARY 2025 126
TABLE 75 DEXCOM, INC.: COMPANY OVERVIEW 127
TABLE 76 DEXCOM, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 128
TABLE 77 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021-JANUARY 2025 129
TABLE 78 DEXCOM, INC.: DEALS, JANUARY 2021-JANUARY 2025 130
TABLE 79 BIOBEAT: COMPANY OVERVIEW 131
TABLE 80 BIOBEAT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 131
TABLE 81 BIOBEAT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025 132
TABLE 82 BIOBEAT: DEALS, JANUARY 2021-JANUARY 2025 133
TABLE 83 TYTOCARE LTD.: COMPANY OVERVIEW 135
TABLE 84 TYTOCARE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 135
TABLE 85 TYTOCARE LTD.: PRODUCT ENHANCEMENTS, JANUARY 2021-JANUARY 2025 136
TABLE 86 TYTOCARE LTD.: DEALS, JANUARY 2021-JANUARY 2025 136
TABLE 87 TYTOCARE LTD.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 136
TABLE 88 ZETO INC.: COMPANY OVERVIEW 137
TABLE 89 ZETO INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 137
TABLE 90 GLOOKO, INC.: COMPANY OVERVIEW 138
TABLE 91 GLOOKO, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 138
TABLE 92 GLOOKO, INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 139
TABLE 93 GLOOKO, INC.: DEALS, JANUARY 2021-JANUARY 2025 139
TABLE 94 GLOOKO, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 140
TABLE 95 WELLDOC, INC.: COMPANY OVERVIEW 141
TABLE 96 WELLDOC, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 141
TABLE 97 WELLDOC, INC.: PRODUCT APPROVALS & ENHANCEMENTS,
JANUARY 2021-JANUARY 2025 142
TABLE 98 WELLDOC, INC.: DEALS, JANUARY 2021-JANUARY 2025 142
TABLE 99 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): COMPANY OVERVIEW 144
TABLE 100 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE):
PRODUCTS/SERVICES/ SOLUTIONS OFFERED 144
TABLE 101 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE):
PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025 145
TABLE 102 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE):
OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 145
TABLE 103 BIOINTELLISENSE, INC.: COMPANY OVERVIEW 146
TABLE 104 BLUE SPARK TECHNOLOGIES, INC.: COMPANY OVERVIEW 147
TABLE 105 ACCURKARDIA, INC.: COMPANY OVERVIEW 148
TABLE 106 AION BIOSYSTEMS, INC.: COMPANY OVERVIEW 148
TABLE 107 BROOK INC.: COMPANY OVERVIEW 149
TABLE 108 AI IN REMOTE PATIENT MONITORING MARKET: RISK ASSESSMENT 152
FIGURE 1 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024 VS. 2030 (USD MILLION) 18
FIGURE 2 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024 VS. 2030 (USD MILLION) 19
FIGURE 3 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER,
2024 VS. 2030 (USD MILLION) 20
FIGURE 4 AI IN REMOTE PATIENT MONITORING MARKET: REGIONAL SNAPSHOT 21
FIGURE 5 AI IN REMOTE PATIENT MONITORING MARKET:
DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 22
FIGURE 6 US MEDIAN HEALTHCARE DATA BREACH SIZE, 2009-2024 28
FIGURE 7 AI IN REMOTE PATIENT MONITORING MARKET:
TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS 32
FIGURE 8 AI IN REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS 34
FIGURE 9 AI IN REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS 36
FIGURE 10 AI IN REMOTE PATIENT MONITORING MARKET: PORTER'S FIVE FORCES ANALYSIS 40
FIGURE 11 PATENT PUBLICATION TRENDS IN AI IN
REMOTE PATIENT MONITORING MARKET, 2015-2024 42
FIGURE 12 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS (JANUARY 2015-DECEMBER 2024) 42
FIGURE 13 TOP PATENT OWNERS/APPLICANTS IN AI IN
REMOTE PATIENT MONITORING MARKET (JANUARY 2015-DECEMBER 2024) 43
FIGURE 14 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN
REMOTE PATIENT MONITORING MARKET, 2019-2023 (USD MILLION) 50
FIGURE 15 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN
REMOTE PATIENT MONITORING MARKET (2023) 51
FIGURE 16 AI IN REMOTE PATIENT MONITORING MARKET:
COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 55
FIGURE 17 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY FOOTPRINT 56
FIGURE 18 AI IN REMOTE PATIENT MONITORING MARKET:
COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 62
FIGURE 19 EV/EBITDA OF KEY VENDORS 64
FIGURE 20 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND
5-YEAR STOCK BETA OF KEY VENDORS 64
FIGURE 21 AI IN REMOTE PATIENT MONITORING MARKET:
BRAND/SOFTWARE COMPARATIVE ANALYSIS 65
FIGURE 22 MEDTRONIC: COMPANY SNAPSHOT 70
FIGURE 23 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 75
FIGURE 24 GE HEALTHCARE: COMPANY SNAPSHOT 82
FIGURE 25 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 86
FIGURE 26 OMRON HEALTHCARE, INC.: COMPANY SNAPSHOT 91
FIGURE 27 RESMED, INC.: COMPANY SNAPSHOT 96
FIGURE 28 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 102
FIGURE 29 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): COMPANY SNAPSHOT 108
FIGURE 30 IRHYTHM INC.: COMPANY SNAPSHOT 111
FIGURE 31 MASIMO: COMPANY SNAPSHOT 124
FIGURE 32 DEXCOM, INC.: COMPANY SNAPSHOT 128
FIGURE 33 AI IN REMOTE PATIENT MONITORING MARKET: RESEARCH DESIGN 150
FIGURE 34 AI IN REMOTE PATIENT MONITORING MARKET:
KEY DATA FROM SECONDARY SOURCES 151
FIGURE 35 AI IN REMOTE PATIENT MONITORING MARKET:
KEY DATA FROM PRIMARY SOURCES 152
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security